Embryonic screening is an assisted reproductive technology that has 3 main components: obtaining an embryo, taking a biopsy of it, and completing a genetic analysis of the biopsy.   This genetic screening can identify numerous characteristics, particularly genetically inherited diseases.  Embryo screening prevents implantation of embryos that would be carrying chromosomal abnormalities likely to cause a pregnancy to abort, thus improving the chance for a successful pregnancy. The procedure for obtaining embryos for preimplantation genetic diagnosis (PGD) or comprehensive chromosome screening (CCS) is identical to that used in IVF.

Controlled ovarian stimulation uses a set of timed hormone supplements to stimulate production of surplus oocytes for harvesting.   Finally, to fertilize the oocyte and create an embryo,  sperm is directly injected into the oocyte, a procedure called intercytoplasmic sperm injection (ICSI).

Learn more about options for genetic screening of embryos:

CCS | Comprehensive Chromosome Screening

PGD |  Preimplantation Genetic Diagnosis

Speak with a board-certified reproductive endocrinologist to discuss whether testing may be an option for you.   Contact us today.  We’re here to help.